The Urinary Microbiome and Its Relationship to the Urinary and Serum Metabolome in Healthy Peri- and Postmenopausal Women
NCT06573827 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-08-27
Summary
The presented project aims to characterize the microbiome of healthy peri- and postmenopausal women and its correlation with the metabolome of urine and serum.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Blood and urine sample evaluation
Blood and urine sample evaluation will be performed in healthy female volunteers.
Sponsors & Collaborators
-
University Hospital Ostrava
lead OTHER
Principal Investigators
-
Jan Krhut, prof.,MD,PhD · University Hospital Ostrava
Eligibility
- Min Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 ·Status: COMPLETED ·Phase: PHASE4
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry
NCT05196061 ·Status: RECRUITING
-
Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population
NCT04887636 ·Status: COMPLETED
-
Assessment of Changes in Vaginal Microbiota Profiles Before and After Vaginal Urogynecologic Surgery
NCT04301401 ·Status: COMPLETED ·Phase: NA
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
NCT03357614 ·Status: COMPLETED ·Phase: PHASE3
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 ·Status: UNKNOWN
-
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
NCT05674032 ·Status: UNKNOWN
-
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
NCT06910878 ·Status: RECRUITING
-
Clinical and Biological Impact of Gut Microbiota in Adult Patients With Bacteremia During the COVID-19 Pandemic
NCT07183722 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Study of Human Microbiota in Healthy and Pathological Conditions
NCT03460392 ·Status: UNKNOWN
-
Clinical Metagenomic of Post-traumatic Infections
NCT05770856 ·Status: COMPLETED
-
Implications of the Human Microbiota for Health and Disease
NCT04203303 ·Status: RECRUITING
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Urinary Tract Infections Caused by ESBL-producing Enterobacteria
NCT03501901 ·Status: COMPLETED
-
Optimization Management Study of Community Urinary Tract Infections Spectrum
NCT03655548 ·Status: COMPLETED
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Carriage Of Multiresistant Bacteria After Travel
NCT01676974 ·Status: COMPLETED
-
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01820793 ·Status: TERMINATED ·Phase: NA
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4